#USA #Irvine #Bright Uro #UroLift System #Glean Urodynamics System

Bright Uro's Strategic Leadership Expansion

In a significant move to bolster its leadership team, Bright Uro, Inc., a pioneering company in the realm of lower urinary tract dysfunction (LUTD), has welcomed two seasoned veterans from the Medtech and urology sectors to its Board of Directors. This strategic enhancement comes as Bright Uro aims to accelerate its commercialization efforts and expand its innovative product lines.

The two new appointees, Joseph DeVivo and Ted Lamson, Ph.D., bring a wealth of experience and expertise that aligns perfectly with Bright Uro's mission. DeVivo, the President, CEO, and Chairman of Butterfly Network, is a well-known figure in the medical device industry, boasting over three decades of leadership in various capacities, including significant roles in digital health. His track record includes guiding companies through transformative growth, making him an asset as Bright Uro scales its operations.

Dr. Lamson, co-founder and co-inventor of the UroLift® System, which has become one of the leading therapies in urology, also joins the team as a Strategic Advisor. His execution of significant clinical innovations throughout his career speaks volumes about his capability to influence Bright Uro's product strategy and market penetration efforts. Lamson’s background includes guiding UroLift through the complexities of FDA clearance and successful commercialization, which are crucial stages for Bright Uro as it seeks to establish its Glean® Urodynamics System in a crowded market.

Bright Uro's Innovative Product Development

Bright Uro is known for its commitment to revolutionizing the urodynamics space through its Glean® Urodynamics System, recognized as the first wireless and catheter-free urodynamics platform capable of conducting multi-channel studies. This innovative system not only enhances the accuracy of urodynamic data collection but also significantly improves the experience for clinicians and patients alike. The inclusion of DeVivo and Lamson in leadership highlights the company’s commitment to maintaining high standards in product development and market delivery.

Both industry leaders have expressed their enthusiasm about joining Bright Uro at this pivotal moment. DeVivo commented, “Glean is doing for urodynamics what connected, data-driven platforms have done across the rest of medtech—replacing a cumbersome, artisanal process with something more streamlined, consistent, and built to scale.” His deep understanding of tech-driven health solutions aligns with Bright Uro's goals, particularly as they continue to refine their products with the support of their proprietary Urodynamic Intelligence™, an AI and machine learning platform aimed at optimizing urodynamic data interpretation.

Dr. Lamson echoes a similar sentiment, emphasizing the importance of creating a successful pathway for clinical adoption of medical innovations. He noted, “UroLift taught me that even clinically transformative technologies only reach patients by building a solid path to adoption.” This perspective is particularly critical for Bright Uro as it navigates the intricacies of introducing its new technologies into clinical practice.

The Leadership's Vision

Derek Herrera, the Founder and CEO of Bright Uro, expressed excitement about these appointments, highlighting their combined experiences that span from clinical insight to the commercialization journey of successful medical devices. “I couldn't be more excited to work alongside and learn from Joe and Ted. They’ve led at every stage of the journey, and their guidance will be invaluable as we rapidly accelerate commercial growth at Bright Uro,” he stated. Herrera’s vision for Bright Uro is rooted in creating reliable partnerships with clinicians and enhancing patient care outcomes through advanced urodynamic solutions.

As Bright Uro embarks on this new chapter, the combination of leadership and innovative technology positions the company as a formidable player in the urology device market. The future looks promising, with expectations for significant advancements in patient care and clinical efficiencies driven by the fresh perspectives on the Board.

About Bright Uro

Based in Irvine, California, Bright Uro is on a mission to revolutionize urodynamics through the development of ultra-modern diagnostic devices. Founded in 2021 by Derek Herrera, who has a notable background as a medical device entrepreneur and former Marine Raider, the company is focused on becoming a trusted partner for clinicians and patients alike. With their expansion into board leadership, Bright Uro is committed to fostering innovation and improving care for individuals facing LUTD. For further details, you can visit GleanUDS.com.